Clinical Trials Directory

Trials / Completed

CompletedNCT02268656

Effect-site Concentration of Propofol for I-gel Insertion During Anesthesia Induction With a Single-dose Dexmedetomidine

Preducted Effect-site Concentration of Propofol for I-gel Insertion During Anesthesia Induction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Gachon University Gil Medical Center · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Before anethetic induction, infuse dexmedetomidine 0.5 mcg/kg for 2 minutes and after injection of lidocaine 30 mg, propofol infusion by using target controlled infusion (TCI) pump. Effect site concentraion of propofol start from 5 and changes the concentration as previous response to i-gel insertion as up and down methods

Detailed description

Before anethetic induction, infuse dexmedetomidine 0.5 mcg/kg for 2 minutes and after injection of lidocaine 30 mg, propofol infusion by using target controlled infusion (TCI) pump. Effect site concentraion of propofol start from 5 and changes the concentration as previous response to i-gel insertion as up and down methods. Failure of previous subjects are defined as difficulty to mouth open, severe nausea and couph and laryngeal spasm, and not loss of consciousness.

Conditions

Interventions

TypeNameDescription
DRUGpropofol concentrationFirst subjects start from effect site concentraion of 5ug/ml propofol, after insertion of i-gel, determine the next subjects' effect site concentraion would be increae or decrease 0.5 ug/ml as up and down method

Timeline

Start date
2014-10-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2014-10-20
Last updated
2022-08-03
Results posted
2022-08-03

Source: ClinicalTrials.gov record NCT02268656. Inclusion in this directory is not an endorsement.